Cell Adhesion Molecules in Heart Failure

This substudy of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) randomized clinical trial investigates the association between cell adhesion molecules and adverse outcomes in chronic heart failure.